Diabetes
From the Journals
Diabetes plus weight loss equals increased risk of pancreatic cancer
"The combination of weight loss and no family history of diabetes at the time of diagnosis should be an even stronger signal for pancreatic cancer...
From the Journals
Does metformin reduce risk for death in COVID-19?
“It is still unclear whether metformin is truly a miracle drug or whether it is simply used more often among people who are healthier and who do...
From the Journals
RA patients show decreased risk for new-onset type 2 diabetes
Treatment with biologic disease-modifying antirheumatic drugs is a likely contributor to the lower risk for type 2 diabetes mellitus.
From the Journals
Screening criteria for diabetes in youth won’t capture all at high risk
A1c in particular appears useful regardless of whether screening criteria are met.
Guidelines
Guidance covers glycemia in dexamethasone-treated COVID-19 patients
The latest document from the COVID-19 response group of the Association of British Clinical Diabetologists is a response to the recent RECOVERY...
From the Journals
Diabetic amputations soared amid Italian pandemic lockdown
Gangrene cases also skyrocketed, suggesting that patients failed to get proper care during national shutdown.
From the Journals
Novel probiotic shows promise in treating type 2 diabetes
Feature
SGLT2 inhibitors have a breakout year
From the Journals
Unexpected rosuvastatin-canagliflozin adverse effect reported
From the Journals
COVID-19 taking financial toll on people in U.S. with diabetes
Unemployment and income loss caused by the pandemic are higher among those with diabetes than in the general U.S. population.
Latest News
Real-world data show SGLT2 inhibitors for diabetes triple DKA risk
The findings are based on the use of three different SGLT2 inhibitors in Canada and the United Kingdom.